Immunotherapy of equine cutaneous lymphosarcome using low dose cyclophosphamide and autologous tumor cells infected with vaccinea virus.

1. Campbell TM, Studdert MJ, Ellis WM, Paton CM. Attempted reconstitution of a foal with primary severe combined immunodeficiency.. Equine Vet J 1983 Jul;15(3):233-7.
   pubmed: 6349983doi: 10.1111/j.2042-3306.1983.tb01776.xgoogle scholar: lookup
2. Cottney J, Bruin J, Lewis AJ. Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.. Agents Actions 1980 Sep;10(4):378-88.
   pubmed: 7446316doi: 10.1007/BF01971444google scholar: lookup
3. Hoon DS, Foshag LJ, Nizze AS, Bohman R, Morton DL. Suppressor cell activity in a randomized trial of patients receiving active specific immunotherapy with melanoma cell vaccine and low dosages of cyclophosphamide.. Cancer Res 1990 Sep 1;50(17):5358-64.
   pubmed: 2143687
4. Archer TP, Bretscher P, Ziola B. Immunotherapy of the rat 13762SC mammary adenocarcinoma by vaccinia virus augmentation of tumor immunity.. Clin Exp Metastasis 1990 Nov-Dec;8(6):519-32.
   pubmed: 2225567doi: 10.1007/BF00135875google scholar: lookup
5. Berd D, Mastrangelo MJ. Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide.. Cancer Invest 1988;6(3):337-49.
   pubmed: 3167614doi: 10.3109/07357908809080657google scholar: lookup

Citations

1. Doyle AJ, MacDonald VS, Bourque A. Use of lomustine (CCNU) in a case of cutaneous equine lymphoma.. Can Vet J 2013 Dec;54(12):1137-41.
   pubmed: 24293673